Fulgent Genetics adopts executive clawback policy for incentive compensation misconduct

Fulgent Genetics, Inc.

Policy applies to Section 16 officers; covers equity awards and cash incentives granted on/after March 28, 2022.
Recoupment triggered by Committee finding of serious misconduct causing material legal/policy violation with significant harm.
No recoupment after change in control or for awards granted more than 3 years before first triggering event.
Company may also recoup compensation as required by law or exchange rules; no indemnification for recouped amounts.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.